Literature DB >> 8258722

Use of C6-deficient rats to evaluate the mechanism of hyperacute rejection of discordant cardiac xenografts.

R B Brauer1, W M Baldwin, M R Daha, S K Pruitt, F Sanfilippo.   

Abstract

C plays a critical role in the hyperacute rejection (HAR) of discordant xenografts (Xg), but the relative contribution of early vs late C components is unknown. In this study, genetic differences in C6 activity were correlated with HAR of guinea pig cardiac Xg by the rat. Seven rat strains were tested for C activity. Six strains (PVG.R1 (R1), PVG.1A (1A), DA, W/F, F344, LEW) had readily detectable C activity in the total and alternative pathways. Some PVG rats also had adequate C activity [PVG (C+)] but others [PVG (C-)] had a profound C6 deficiency. All rats with adequate C activity (n = 35) rejected cardiac Xg between 15 and 80 min. PVG (C+) (n = 6) rats also rejected cardiac Xg hyperacutely (26 +/- 12 min), whereas PVG (C-) (n = 16) rats, which had high preformed IgM natural antibody titers, rejected cardiac Xg in 1 to 2 days (2678 +/- 542 min). Transfer of serum from R1 rats to PVG (C-) recipients with vigorously beating Xg caused HAR of cardiac Xg within 116 +/- 75 min. Transfer of fresh PVG (C-) serum or heat-inactivated R1 serum did not induce HAR. HAR was characterized by intravascular platelet aggregation and interstitial hemorrhage, whereas Xg transplanted to PVG (C-) recipients had patent vessels at 30 min but were heavily infiltrated by granulocytes and monocytes at 2 days. These findings indicate that a deficiency in C6 prevents HAR but allows an accelerated acute rejection that may be mediated by the generation of vasoactive and chemotactic C3a and C5a.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8258722

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

Review 1.  Recent advances in the immunology of xenotransplantation.

Authors:  T Takahashi; S Saadi; J L Platt
Journal:  Immunol Res       Date:  1997       Impact factor: 2.829

2.  Immune complex formation after xenotransplantation : evidence of type III as well as type II immune reactions provide clues to pathophysiology.

Authors:  Z E Holzknecht; S Coombes; B A Blocher; T B Plummer; M Bustos; C L Lau; R D Davis; J L Platt
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

Review 3.  Animal models of inherited complement deficiency.

Authors:  S Linton
Journal:  Mol Biotechnol       Date:  2001-06       Impact factor: 2.695

4.  Complement membrane attack is required for endplate damage and clinical disease in passive experimental myasthenia gravis in Lewis rats.

Authors:  J Chamberlain-Banoub; J W Neal; M Mizuno; C L Harris; B P Morgan
Journal:  Clin Exp Immunol       Date:  2006-11       Impact factor: 4.330

5.  Endotoxin-induced lung inflammation is independent of the complement membrane attack complex.

Authors:  R B Brauer; C Gegenfurtner; B Neumann; M Stadler; C D Heidecke; B Holzmann
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

6.  Requirement and role of C5a in acute lung inflammatory injury in rats.

Authors:  M S Mulligan; E Schmid; B Beck-Schimmer; G O Till; H P Friedl; R B Brauer; T E Hugli; M Miyasaka; R L Warner; K J Johnson; P A Ward
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

7.  C6 produced by macrophages contributes to cardiac allograft rejection.

Authors:  Z Qian; B A Wasowska; E Behrens; D L Cangello; J R Brody; S S Kadkol; L Horwitz; J Liu; C Lowenstein; A D Hess; F Sanfilippo; W M Baldwin
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

Review 8.  The role of antibodies in transplantation.

Authors:  Alexander T Chang; Jeffrey L Platt
Journal:  Transplant Rev (Orlando)       Date:  2009-07-22       Impact factor: 3.943

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.